Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: AS Software, Asieris, Boehringer Ingelheim, Deephealth, Eli Lilly, Ipsen, Moderna, Neurogene, Novartis, Optellum, Photocure, Regeneron, Sanofi, Sentynl, Synergy Spine Solutions, X4.